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Abstract 
The importance of the working document is that it allows the analysis of the information and the status of 
cases associated with (SARS-CoV-2) COVID-19 as open data at the municipal, state and national level, with a 
daily record of patients, according to a age, sex, comorbidities, for the condition of (SARS-CoV-2) COVID-19 
according to the following characteristics: a) Positive, b) Negative, c) Suspicious. Likewise, it presents 
information related to the identification of an outpatient and / or hospitalized patient, attending to their 
medical development, identifying: a) Recovered, b) Deaths and c) Active, in Phase 3 and Phase 4, in the five 
main population areas speaker of indigenous language in the State of Veracruz - Mexico. The data analysis is 
carried out through the application of a data mining algorithm, which provides the information, fast and 
timely, required for the estimation of Medical Care Scenarios of (SARS-CoV-2) COVID-19, as well as for know 
the impact on the  indigenous language-speaking population in Mexico.  
Keywords 
(SARS-CoV-2) COVID-19, Algorithm (SARS-CoV-2) COVID-19, Mexico, identification of patients, Popoluca 
from the Soteapan Zone 
 
Specifications Table 
Subject Infectious Diseases 
Specific subject area Information from the Viral Respiratory Diseases Epidemiological 
Surveillance System for (SARS-CoV-2) COVID-19 in Mexico corresponding 
to the indigenous language-speaking population in Mexico. 
Type of data Table 
Figure 
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How data were acquired Government of Mexico. Health Secretary. Databases Covid-19 México 
https://datos.gob.mx/busca/dataset/informacion-referente-a-casos- 
covid-19-en-mexico/resource/e8c7079c-dc2a-4b6e-8035-08042ed37165 
Instruments: 
Software Orange Data Mining version 3.26.0 https://orange.biolab.si 
Make and model and of the instruments used: 
Algorithm for the identification of patients according to following 
characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it presents 
information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b) Deaths and c) Assets 
Data format The information is presented in raw in CVS format, the Ministry of Health 
of Mexico since April 14, 2020 published the cases associated with (SARS- 
CoV-2) COVID-19 as open data. The data processing corresponds to the 
records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 2020. The 
treatment of the information is carried out through the application 
software for data mining Orange version 3.26.0, in which the algorithm for 
the analysis of information is filtered to present the current scenario of the 
indigenous language-speaking population in Mexico of the SARS-CoV-2 
(COVID 19). 
Parameters for data 
collection 
The information is presented at the municipal, state and national levels, 
with a daily registry of patients, according to age, sex, comorbidities, for 
the condition of (SARS-CoV-2) COVID-19 according to the following 
characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it presents 
information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b) Deaths and c) Assets. 
Study area The states that comprise the indigenous language speaking population in 
Mexico are:  Aguascalientes … Zacatecas 
Description of data 
collection 
This information is filtered to present the current scenario in the 
indigenous language speaking population in Mexico of the SARS-CoV-2 
(COVID 19) in a fast and timely manner, to support public decision-making 
in health matters. 
Data source location Institution: Universidad Veracruzana / Instituto de Investigaciones y 
Estudios Superiores Económicos y Sociales 
Country: México 
Data accessibility Raw data can be retrieved from the Github repository 
https://github.com/CMedelR/dataCovid19/edit/master/README.md 
 
   Value of the Data 
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• The Algorithm for the identification of patients (SARS-CoV-2) COVID 19 in Mexico allows to analyze at 
the municipal, state and national level, the registry of patients, according to age, sex, comorbidities, 
for condition of (SARS-CoV-2) COVID-19 according to the following characteristics: a) Positive, b) 
Negative, c) Suspicious, as well as presenting information on the identification of an outpatient and / 
or hospitalized patient, attending to their medical development, identifying: a) Recovered, b ) Deaths 
and c) Assets, in Phase 3 and Phase 4, in a fast and timely manner, to support public decision-making 
in health matters. 
• Taking into account their strategic roles in public health and researchers can use the data from this 
study to identify the action scenario for decision-making in the combat of (SARS-CoV-2) COVID 19 in 
Phase 3 and Phase 4 corresponding to the indigenous language speaking population in Mexico 
• The importance of data analysis is that it allows identifying cases (SARS-CoV-2). COVID-19 in Mexico 
is concentrated daily and knowing the impact on the population and allows preparing action scenarios 
to make public health policy decisions to combat SARS-CoV-2) COVID-19 in the indigenous language 
speaking population in Mexico 
 
Data Description 
 
The source of information on the number of registered cases of (SARS-CoV-2) COVID-19 at 1 August 2020 for 
Mexico comes from the website https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-covid- 
19-en-mexico by the Ministry of Health, with the participation of the National Council for Science and 
Technology (CONACYT), the Center for Research in Geospatial Information Sciences (CENTROGEO), the 
National Laboratory for Geo-Intelligence (GEOINT), the Data Laboratory of the National Laboratory for 
Geointelligence (DataLab), where the registry of COVID-19 cases (SARS-CoV-2) COVID-19 is concentrated, and 
is the official means of communication and information on the epidemic in the Popoluca from the Soteapan 
Area in Mexico. 
 
The information of the cases (SARS-CoV-2) COVID-19 in Mexico is concentrated on a daily basis since April 19, 
2020, communication and official information on the epidemic in Mexico, the data are presented at the 
municipal, state and national levels, with a daily registry of patients, according to age, sex, comorbidities, for 
the condition of (SARS-CoV-2) COVID-19 according to the following characteristics: a) Positive, b) Negatives, 
c) Suspects. Likewise, it presents information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: a) Recovered, b) Deaths and c) 
Assets. The data processing corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 
2020. The treatment of the information is carried out through the application software for data mining and 
visual programming Orange Data Mining version 3.26.0. Orange Data Mining is a machine learning and data 
mining suite for data analysis through Python scripting and visual programming. [1] 
 
According to (WHO, 2020) the (SARS-CoV-2) COVID-19 disease pattern presents 4 scenarios identified from 
the confirmation of Laboratory Diagnosis: a) Not Infected or b) Infected, in this finally, the following categories 
are observed, taking into account age and specific comorbidities in each case: a) Mild Infection, b) Moderate 
Infection, c) Severe Infection and d) Critical Infection. 
 
Depending on the category observed in Patients who have a Confirmation of Infected, as in the case of a) or 
b) it can assume the character of Outpatient, so the strategy is isolation or "quarantine" at home, where the 
result It is hoped that he will recover. Regarding the Patients who have a Confirmation of Infected, in 
categories c) and d) they assume the character of Hospitalized Patient, with a probability of requiring care in 
Intensive Care Units and requiring Intubation, and where it is hoped to save as many patients as possible. 
Working paper: Data mining for the study of the COVID-19 Epidemic (SARS-CoV-2) and the impact on the indigenous population in Veracruz: 
Algorithm for the identification of COVID patients (SARS-CoV-2), August to 1, 2020 
 
The importance of the research is that it allows identifying the action scenario for making public health policy 
decisions to combat CO(SARS-CoV-2) COVID-19, since they consider the following states of process in medical 
treatment, in order to carry out the Estimate of Scenarios for Medical Care of the (SARS-CoV-2) COVID-19 
under the following premises of hospital care: 
1. A patient with a positive (SARS-CoV-2) COVID-19 laboratory diagnosis can be considered: a) Outpatient, 
or b) Hospitalized. 
2. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized, the following should be considered: a) 
Enter the Intensive Care Unit or b) Do not enter the Intensive Care Unit. 
3. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized and Entered into the Intensive Care Unit, 
the following should be considered: a) The patient requires intubation or b) The patient does NOT require 
intubation. 
 
Methods 
 
The information is presented in raw in CVS format, the Ministry of Health of Mexico. The data processing 
corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 2020. The treatment of the 
information is carried out through the application software for data mining Orange version 3.26.0, in which 
the algorithm for the analysis of information are developed and it is filtered to present the current scenario 
in Mexico of the SARS-CoV-2 (COVID 19). In this way, the algorithm that is presented allows us to project the 
requirements for the use of installed infrastructure in the face of the growing requirement for patient care 
Positive (SARS-CoV-2) COVID-19, allowing the identification of scenarios at the national, state and municipal 
levels. The construction of the algorithm is based on the following definitions. 
 
Definition 1: Total Patients to consider in Model (SARS-CoV-2) COVID-19.- It is the number of total patients 
according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
Be: 
TP SARS-CoV-2 i j = Total patients according to (SARS-CoV-2) COVID-19 confirmatory laboratory result 
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- SARS-CoV-2 i j) + (Px SARS-CoV-2 i j), where: i = State, j = 
Municipality 
Of which: 
P+ SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
P- SARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Municipality 
Px SARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State, Municipality 
 
Definition 2: Identification of a suspected (SARS-CoV-2) COVID-19 case.- This is the patient who undergoes 
an initial qualification according to the initial diagnostic characteristics indicated in the case definitions for 
surveillance by the World Health Organization for primary care of (SARS-CoV-2) COVID-19 cases. 
Be: 
CsCOVID 19 (SARS-CoV-2) = Patient with initial classification as a suspected case of (SARS-CoV-2) COVID-19 
Where: 
Cs (SARS-CoV-2) COVID-19 = Cs (SARS-CoV-2) COVID-19 Type 1 + Cs (SARS-CoV-2) COVID-19 Type 2 + Cs (SARS- 
CoV-2) COVID-19 Type 3 
Of which: 
According to the World Health Organization, there are 3 categories (identified as Type 1, Type 2 and Type 3) 
to identify suspected cases of (SARS-CoV-2) COVID-19, defined below: 
1. Cs (SARS-CoV-2) COVID-19 Type 1.- Is a patient with acute respiratory disease (fever and at least one 
sign / symptom of respiratory disease, with no other aetiology that fully explains the clinical 
presentation and a history of travel or residence in a country / area or territory that reports local 
transmission of COVID-19 disease during the 14 days prior to the onset of symptoms. 
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2. Cs (SARS-CoV-2) COVID-19 Type 2.- He is a patient with an acute respiratory disease, who has been in 
contact with a confirmed or probable COVID-19 case in the last 14 days before the onset of symptoms. 
3. Cs (SARS-CoV-2) COVID-19 Type 3.- Is a patient with severe acute respiratory infection (fever and at 
least one sign / symptom of respiratory illness (eg cough, shortness of breath) and requiring 
hospitalization and without another etiology that fully explains the clinical presentation. 
 
Definition 3: Total Patients to consider in the (SARS-CoV-2) COVID-19 Model .- It is the number of total 
patients according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
Be: 
TP SARS-CoV-2 i j = Total patients according to confirmatory laboratory result or not of (SARS-CoV-2) COVID- 
19 
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- ARS-CoV-2 i j) + (Px ARS-CoV-2 i j) , where: i = State, j = 
Municipality 
Of which: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
P- ARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Municipality 
Px ARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State, Municipality 
 
Definition 4: Positive Patients for (SARS-CoV-2) COVID-19 i j.- It is the number of patients with laboratory 
results with positive confirmation for (SARS-CoV-2) COVID-19 i j . 
It has: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Municipality 
 
Definition 5.- Medical Treatment Strategy for a patient with positive laboratory confirmation for (SARS-CoV- 
2) COVID-19 i j .- It is the Action Plan in Medical Treatment for a patient with positive laboratory confirmation 
for SARS-CoV-2 in attention to your degree of infection and comorbidities present that is channeled to 
determine the Physician. 
 
According to the Strategy of Medical Care required for Patients with a Positive SARS-CoV-2 Result, according 
to their degree of identified infection, they have the following. 
Be: 
ET P + SARS-CoV-2 i j = Medical Treatment Strategy P + SARS-CoV-2 i j 
 
The medical treatment for a patient with a positive laboratory result for (SARS-CoV-2) COVID-19, based on 
the Medical Treatment Strategy (ETM P + SARS-CoV-2 ij), based on his degree of infection and present 
comorbidities, poses two action scenarios : i) Outpatient (SARS-CoV-2) COVID-19 patient or ii) Hospitalized 
(SARS-CoV-2) COVID-19 patient. 
Be: 
i) Outpatient COVID19 patient. 
P + SARS-CoV-2 i j Outpatient = Positive (SARS-CoV-2) COVID-19 with Outpatient mode in the State, 
Municipality 
ii) COVID19 Patient Hospitalized. 
P + SARS-CoV-2 i j Hospitalized = Positive (SARS-CoV-2) COVID-19 with modality Hospitalized in the State, 
Municipality 
where: 
Depending on the degree of infection (I1, I2 or I3), the Hospitalized (SARS-CoV-2) COVID-19 Patient may 
require: i) Access to the Intensive Care Area without Intubation or ii) Access to the Intensive Care Area with 
Intubation. 
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Definition 6.- Patients with a Positive (SARS-CoV-2) COVID-19 Result Hospitalized with Access to the 
Intensive Care area.- It is the number of Patients with a Positive SARS-CoV-2 Result Hospitalized with Access 
to the Intensive Care area, according to its degree of infection. 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care = Positive (SARS-CoV-2) COVID-19 with modality 
Hospitalized in the State, Municipality 
Definition 7.- Patients with a positive (SARS-CoV-2) COVID-19 result Hospitalized with access to the Intensive 
Care Area with Intubation.- It is the number of Patients with a Positive (SARS-CoV-2) COVID-19 Result 
Hospitalized with Access to the Intensive Care area with Intubation. 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care with Intubation = Positive (SARS-CoV-2) COVID-19 with Hospitalized 
modality and intubation in the State, Municipality. 
 
Definition 8.- P + SARS-CoV-2 i j Deaths.- Deaths of Patients with a positive result for SARS-CoV-2. Deaths are 
all those positive to (SARS-CoV-2) COVID-19 where one is indicated in the data record (DATE_DEF other than 
the value "99-99-9999"). 
 
Definition 9.- (SARS-CoV-2) COVID-19 case fatality rate.- It is the proportion of people who die from (SARS- 
CoV-2) COVID-19 among the Patients with a positive (SARS-CoV-2) COVID-19 result in a given period and area. 
Be: 
TL SARS-CoV-2 i j = (SARS-CoV-2) COVID-19 case fatality rate 
Where: 
(SARS-CoV-2) COVID-19 case fatality rate = [(Deaths of Patients with a Positive (SARS-CoV-2) COVID-19 Result 
in the State or Municipality) / (Total of Patients with a Positive (SARS-CoV-2) COVID-19 result in the State or 
Municipality)] x 100 
Of which: 
DP+ SARS-CoV-2 i j = Deaths of Patients with a positive (SARS-CoV-2) COVID-19 result in the State / 
Municipality 
And: 
P+ SARS-CoV-2 i j = Total Patients with a positive (SARS-CoV-2) COVID-19 result in the State / Municipality 
So: 
TL SARS-CoV-2 i j = [D P + SARS-CoV-2 i j / P + SARS-CoV-2 i j] x 100 
 
The data processing corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 1 August 2020. 
The treatment of the information is carried out through the application software for data mining Orange 
version 3.26.0, in which the algorithm for the information analysis are developed. (See Figure 1, below). 
According to information from the Ministry of Health, the following records are available at the national level: 
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Figure 1. Algorithm for the identification of patients (SARS-CoV-
2) COVID 19 in the indigenous language speaking population in 
Mexico Orange Data Mining version 3.26.0 
 
 
 
 
 
 
Source: Self made. With information provided by the Ministry of Health as of 1 June 2020 and Orange 
Data Mining version 3.25.1 
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According to information from the Ministry of Health in Mexico, the following records are available at the 
national level: 
 
1. The total number of cases in the indigenous language-speaking population in Mexico as of august 1, 
2020, is 8,938 cases of which, based on the confirmatory or non-laboratory result for (SARS-CoV-2) 
COVID-19, the following classification is obtained: a ) 4,555 patients with a positive result for (SARS-
CoV-2) COVID-19, b) 3,780 patients with a non-positive result for (SARS-CoV-2) COVID-19 and c) 603 
patients with a pending result to determine (SARS-CoV -2) COVID-19. (See table 1) 
2. The number of patients  indigenous language-speaking population with a positive (SARS-CoV-2) 
COVID-19 result is 4,555 of which: a) 5,909 are care outpatients and b) 3,029 are hospitalized patients. 
(See table 2) 
3. The total number of patients (SARS-CoV-2) COVID-19 hospitalized (include positive and non positive 
results) is 3,209 of whom 1,253 are women and 1,776 are men. (See Table 3) 
4. The total number of hospitalized patients with a positive result for (SARS-CoV-2) COVID-19 is 1,830, of 
whom: a) 164 patients enter the intensive care unit; while b) 1,666 patients do not enter the intensive 
care unit. (See Table 4) 
5. Only 84 Hospitalized with a positive (SARS-CoV-2) COVID-19 patients admitted to the intensive care 
unit required intubation; while 80 patients did not require intubation. (See Table 5) 
6. Likewise, to date 3,486 deceased patients indigenous language-speaking population in Mexico with 
positive (SARS-CoV-2) COVID-19 have been registered, of which 67  deaths corresponded to Positive 
(SARS-CoV-2) COVID-19 patients who were in intensive care and intubation and 3,419 corresponded 
to (SARS-CoV-2) COVID-19 positive patients who were not in intensive care. (See Table 6). 
7. The fatality rate of patients with a positive result for SARS-CoV-2) COVID-19 at nationwide as of august 
1, 2020, is estimated at 10.93%. The five states that registered the highest fatality rates as of August 
1, 2020 are the following: a) Morelos with a rate of 2039%, b) Baja California with 19.67%, c) Sinaloa 
with a rate of 17.46% , d) Colima with a rate of 17: 00% and e) State of Mexico with a rate of 15.37%. 
For its part, the State of Veracruz registered a rate of 13.20% while Mexico City registered a rate of 
9.75% (See Table 7). 
8. The fatality rate of patients indigenous language-speaking population in Mexico with a positive result 
for SARS-CoV-2) COVID-19 at nationwide as of august 1, 2020, is estimated at  (See Table 8). 
9. Figure 1 shows the main comorbidities identified in hospitalized patients indigenous language-
speaking in Mexico with  a positive result for (SARS-CoV-2) COVID-19, nationwide as of August 1, 2020. 
10. The Map 1  (SARS-CoV-2) COVID-19 fatality rate by State in Mexico as of August 1, 2020, while Map 2 
shows the fatality rate for COVID-19 (SARS-CoV-2) in the indigenous-speaking population that 
required service in Intensive Care Units in Mexico by state as of August 1, 2020. 
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Table 1. Total number of cases in the indigenous language-speaking 
population in Mexico as of August 1, 2020, according to sex and result for 
(SARS-CoV-2) COVID-19 
 
  Sex  
Result Women Men Total 
Positive (SARS-CoV-2) COVID-19      1,845      2,710        4,555 
No positive (SARS-CoV-2) COVID-19        1,937      1,843           3,780 
Pending result     286       317              603 
Total    4,068      4,870           8,938 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
 
Table 2. Total number of cases in the indigenous-speaking population in 
Mexico as of August 1, 2020, by type of hospital care 
 
 
  Patient type  
Result Ambulatory Hospitalized Total 
Positive (SARS-CoV-2) COVID-19       2,722      1,833        4,555 
No positive (SARS-CoV-2) COVID-19           2,757   1,023           3,780 
Pending result       430      173              603 
Total      5,909     3,029           8.938 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
 
Table 2. Total number of cases in the indigenous-speaking population in 
Mexico as of August 1, 2020, according to sex and of hospital care 
 
   Patient type                        
Sex Ambulatory Hospitalized  Total 
Women      2,815   1,253     4,068 
Men      3,094     1,776     4,870 
Total      5,909     3,029     8,938 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
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unit 
patient 
Table 4. Total number of cases in the indigenous-speaking population in 
Mexico as of August 1, 2020,  according type of patient and Intensive care unit 
 
Patient type 
Intensive care No Intensive care 
unit 
 
Total 
 
Hospitalized 164 1,666       1,830 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
 
 
Table 5. Total number of cases in the indigenous-speaking population in 
Mexico as of August 1, 2020 according to hospitalized patient in intensive care 
unit and intubation condition 
 
 
Patient type 
Intubated
 
No 
Intubated 
patient 
Total 
Hospitalized 
intensive care 
unit 
 
84                           80             164
 
 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 August 
2020 
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Table 6. Total number of cases in the indigenous-speaking population in Mexico as 
of August 1, 2020 with positive COVID-19 (SARS-CoV-2), according to hospital care 
condition as of August 1, 2020 
  
Patient type  Women Men  Total  
 
At the national 
level 
 1,085   2,401  3,486  
 
Intensive care 
unit patients with 
intubation 
 18   49  67  
 
% Deceased 
patients requiring 
care in intensive 
and intubation, by 
sex 
 1.66%   2.04%  1.92%  
 
 
Source: Government of Mexico. Health Secretary. Information from the 
Epidemiological Surveillance System for Viral Respiratory Diseases 1 
August 2020 
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Table 7. (SARS-CoV-2) COVID-19 fatality rate by State in Mexico 
as of August 1, 2020 
 Estado Total deceased Covid positives 19 Case fatality rate 
1 Aguascalientes 257 4,120 6.24% 
2 Baja California 2,674 13,594 19.67% 
3 Baja California Sur 182 4,498 4.05% 
4 Campeche 500 4,588 10.90% 
5 Chiapas 645 13,116 4.92% 
6 Chihuahua 194 1,875 10.35% 
7 Ciudad de México 7,244 74,314 9.75% 
8 Coahuila de Zaragoza 967 5,775 16.74% 
9 Colima 904 5,317 17.00% 
10 Durango 288 4,167 6.91% 
11 Guanajuato 1,009 21,378 4.72% 
12 Guerrero 1,415 11,032 12.83% 
13 Hidalgo 1,033 6,901 14.97% 
14 Jalisco 1,549 13,313 11.64% 
15 México 8,225 53,513 15.37% 
16 Michoacán de Ocampo 780 9,910 7.87% 
17 Morelos 836 4,101 20.39% 
18 Nayarit 391 3,518 11.11% 
19 Nuevo León 1,118 18,032 6.20% 
20 Oaxaca 968 10,673 9.07% 
21 Puebla 2,446 20,355 12.02% 
22 Querétaro 449 3,726 12.05% 
23 Quintana Roo 1,015 7,840 12.95% 
24 San Luis Potosí 522 9,921 5.26% 
25 Sinaloa 2,230 12,774 17.46% 
26 Sonora 1,949 17,890 10.89% 
27 Tabasco 1,988 21,747 9.14% 
28 Tamaulipas 1,008 17,130 5.88% 
29 Tlaxcala 713 4,627 15.41% 
30 Veracruz de Ignacio de la Llave 2,849 21,582 13.20% 
31 Yucatán 875 10,098 8.67% 
32 Zacatecas 249 2,768 9.00% 
 Total 47,472 434,193 10.93% 
 
Source: Own elaboration with Government of Information from the Mexico. Health 
Secretary. Epidemiological Surveillance System for Viral Respiratory Diseases as of 
August 1, 2020 
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Map 1  (SARS-CoV-2) COVID-19 fatality rate by State in Mexico as of August 1, 2020 
 
 
 
 
 
Source: Own elaboration with Government of Information from the Mexico. Health 
Secretary. Epidemiological Surveillance System for Viral Respiratory Diseases as of 
August 1, 2020 
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Table 8. (SARS-CoV-2) COVID-19 fatality rate on the indigenous language-speaking 
population in Mexico by State in Mexico as of August 1, 2020 
 
 
 
 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of August 1, 2020 
 
 
Estado Total deceased Covid positives 19 Case fatality rate
1 Aguascalientes 8 0.00
2 Baja California 81 0.00
3 Baja California Sur 6 0.00
4 Campeche 1 124 0.81
5 Chiapas 23 0.00
6 Chihuahua 7 0.00
7 Ciudad de México 5 149 3.36
8 Coahuila de Zaragoza 3 45 6.67
9 Colima 2 318 0.63
10 Durango 4 28 14.29
11 Guanajuato 45 0.00
12 Guerrero 5 228 2.19
13 Hidalgo 4 257 1.56
14 Jalisco 3 41 7.32
15 México 9 329 2.74
16 Michoacán de Ocampo 138 0.00
17 Morelos 1 38 2.63
18 Nayarit 54 0.00
19 Nuevo León 41 0.00
20 Oaxaca 18 410 4.39
21 Puebla 1 200 0.50
22 Querétaro 9 0.00
23 Quintana Roo 2 253 0.79
24 San Luis Potosí 276 0.00
25 Sinaloa 31 0.00
26 Sonora 1 116 0.86
27 Tabasco 127 0.00
28 Tamaulipas 19 0.00
29 Tlaxcala 30 0.00
30
Veracruz de Ignacio de la 
Llave
1 131 0.76
31 Yucatán 7 979 0.72
32 Zacatecas 14 0.00
Total 67 4,555 1.47
16  
 
Map 2  (SARS-CoV-2) COVID-19 fatality rate on n the indigenous-speaking population 
that required service in Intensive Care Units 
in Mexico by state as of August 1, 2020 
 
 
 
Source: Own elaboration with Government of Information from the Mexico. Health 
Secretary. Epidemiological Surveillance System for Viral Respiratory Diseases as of 
August 1, 2020 
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Figure 1 Comorbidities identified in hospitalized Indigenous-language-
speaking patients with a positive result for (SARS-CoV-2) 
COVID-19, nationally as of August 1, 2020 
 
        Sex         Age 
          Sex =1 Women, Sex = 2 Men 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of August 1, 2020 
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